Integrated Diagnostics Holdings plc (LON:IDHC)

Market Cap	239.67M +66.4%
Revenue (ttm)	114.96M +42.9%
Net Income	20.48M +55.5%
EPS	0.04 +55.5%
Shares Out	581.33M
PE Ratio	11.61
Forward PE	13.29
Dividend	0.01 (3.01%)
Ex-Dividend Date	n/a

Volume	63,626
Average Volume	120,246
Open	0.5500
Previous Close	0.5650
Day's Range	0.5400 - 0.5700
52-Week Range	0.3050 - 0.8300
Beta	0.28
RSI	36.69
Earnings Date	Apr 8, 2026

About LON:IDHC

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 6,309
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IDHC

Financial Performance

In 2024, LON:IDHC's revenue was 5.72 billion, an increase of 38.74% compared to the previous year's 4.12 billion. Earnings were 1.08 billion, an increase of 111.14%.

Financial numbers in EGP